Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$27,000.00
Investigating YAP/TAZ-mediated regulation of the spindle assembly checkpoint in lung cancer
EF 2024-25
Résumé
Lung cancer is the world deadliest cancer. A major obstacle to treating this cancer is the ability of tumours to resist the toxic effects of drugs. This project aims to understand the biological processes that contribute to drug resistance and tumour growth, which could help identify new treatment strategies. Cells grow and divide during a carefully regulated life cycle known as the cell cycle. The cell cycle has several checkpoints to assess the health of the cell at different stages to prevent unhealthy cells from dividing. One of these checkpoints is the spindle assembly checkpoint, which ensures that the cell duplicated genetic material, packaged into structures called chromosomes, is properly arranged for correct division into two new cells. This checkpoint is critical for preventing abnormal genetic changes. In cancer cells, loss of cell cycle control and defective checkpoints lead to uncontrolled growth and genetic changes that support cancer development and progression. Interestingly, recent studies suggest that YAP and TAZ, two proteins that contribute to lung cancer progression and drug resistance, might be involved in regulating the spindle assembly checkpoint. However, it is unclear how this regulation occurs. Based on preliminary data, we suspect that YAP and TAZ interact with components of the checkpoint and interfere with its function. To address this idea, we will characterize how YAP/TAZ influence spindle assembly checkpoint activation in lung cancer cells. We will also determine whether YAP/TAZ interact with specific checkpoint proteins. We expect this work to uncover new ways in which YAP/TAZ contribute to lung cancer and cell cycle abnormalities, which could help us identify novel cancer drug targets and strategies to overcome drug resistance.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
529953
Name
Zou Kangni
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating YAP/TAZ-mediated regulation of the spindle assembly checkpoint in lung cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cell Cycle; Lung Cancer; Spindle Assembly Checkpoint; Yap/Taz
Abstract
Lung cancer is the world deadliest cancer. A major obstacle to treating this cancer is the ability of tumours to resist the toxic effects of drugs. This project aims to understand the biological processes that contribute to drug resistance and tumour growth, which could help identify new treatment strategies. Cells grow and divide during a carefully regulated life cycle known as the cell cycle. The cell cycle has several checkpoints to assess the health of the cell at different stages to prevent unhealthy cells from dividing. One of these checkpoints is the spindle assembly checkpoint, which ensures that the cell duplicated genetic material, packaged into structures called chromosomes, is properly arranged for correct division into two new cells. This checkpoint is critical for preventing abnormal genetic changes. In cancer cells, loss of cell cycle control and defective checkpoints lead to uncontrolled growth and genetic changes that support cancer development and progression. Interestingly, recent studies suggest that YAP and TAZ, two proteins that contribute to lung cancer progression and drug resistance, might be involved in regulating the spindle assembly checkpoint. However, it is unclear how this regulation occurs. Based on preliminary data, we suspect that YAP and TAZ interact with components of the checkpoint and interfere with its function. To address this idea, we will characterize how YAP/TAZ influence spindle assembly checkpoint activation in lung cancer cells. We will also determine whether YAP/TAZ interact with specific checkpoint proteins. We expect this work to uncover new ways in which YAP/TAZ contribute to lung cancer and cell cycle abnormalities, which could help us identify novel cancer drug targets and strategies to overcome drug resistance.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zou, Kangni
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~